Explore our ACCC 2020 Impact Report, the Oncology Issues, Vol.36, N.4, and our video podcast, CANCER BUZZ TV.



In This Section

Home / Learn / Cancer Types / Breast Cancer

Breast Cancer

Among American women, breast cancer is the most common cancer, after skin cancer. About 1 in 8 (12 percent) women in the U.S. will develop invasive breast cancer during their lifetime.

For 2018, the American Cancer Society estimates that:

  • About 266,120 new cases of invasive breast cancer will be diagnosed in women, and about 2,470 will be diagnosed in men.
  • About 63,960 new cases of carcinoma in situ (CIS) will be diagnosed (CIS is non-invasive and is the earliest form of breast cancer).
  • About 40,920 women will die from breast cancer.

Incidence rates of breast cancer are highest in non-Hispanic white women; however, breast cancer death rates are highest in African American women.
Source: American Cancer Society Breast Cancer Facts & Figures 2017-2018.

Breast cancer is the second leading cause of cancer death in women, surpassed only by lung cancer. Death rates from breast cancer have been declining since about 1989, with larger decreases in women younger than age 50. It is believed that earlier detection through screening and increased awareness, as well as improved treatment, has led to these decreases.

Today, there are more than 3.1 million breast cancer survivors in the U.S., including those still being treated and those who have completed treatment.
Source: American Cancer Society. Cancer Facts and Figures 2018. Atlanta, Ga: American Cancer Society; 2018.

Featured Programs

Making Sense of the Evolving Standards of Care for Advanced HER2+ Breast Cancer

This project will enable a series of meaningful small-group educational sessions among clinicians involved in the care of patients with breast cancer. The sessions will help those clinicians optimally manage HER2-positive breast cancer patients who have received prior treatment with anti-HER2 targeted therapies.
Learn More

Find Metastatic Breast Cancer Resources Fast

The ACCC Metastatic Breast Cancer Project’s online resource bank connects you to curated materials (webinars, articles, blogs, and more) to help close communication, education, and information gaps for patients and providers.

Search by topic, resource type (e.g., webinar, article, blog, tool), place in care continuum, or by the effective practices identified in the ACCC Metastatic Breast Cancer Project Workbook and latest case studies in Metastatic Breast Cancer: Effective Principles in Action.
Learn More & Explore the Resource Library

Project ECHO: Bone Health in Patients with Breast and Prostate Cancers

Through a partnership with the American Cancer Society and Project ECHO, ACCC is offering the latest content knowledge and best practices related to bone health in patients with breast cancer and patients with prostate cancer.

Project ECHO teleclinics are basically virtual grand rounds using a hub and spoke model. Cancer care teams (physicians, nurses, social workers, navigators) from multiple locations connect at regularly scheduled times with a team of specialists using low-cost multipoint videoconferencing. During ECHO clinics, participants (spokes) present patient cases to expert teams (hub) who mentor the providers to manage patients with complex conditions. These case-based discussions are supplemented with short didactic presentations by the expert teams to improve content knowledge and share evidence-based best practices.

Participation in the ECHO Clinic is free. Sessions are held monthly by videoconference.
View Topics & Schedule

Quality Improvement in Breast Cancer Through BRCA Testing

To support quality improvement (QI) projects in breast cancer, ACCC has partnered with Pfizer Global Medical Grants to award more than $1.8 million in funding to 15 projects that are aimed at improving the quality of breast cancer patient care. The projects are focused on conducting quality improvement initiatives that support increasing the rates of BRCA testing for patients with early stage or metastatic breast cancer. The grant awards are providing an opportunity for community oncology programs to implement initiatives that will address barriers to counseling and testing, and to utilize innovative approaches to extend best practices to a much larger patient population, including underserved minority patient groups.
Learn More

Managing Patients with HER2+ Breast Cancer

ACCC is partnering with AXIS Medical Education in an educational research project to assess the value of a robust, independent, quality-focused educational intervention that aims to improve a community cancer program's quality measures related to management of patients with HER2+ breast cancer (all stages). Two ACCC-member Cancer Programs are participating in the project.
Learn More


On-Demand Webinars


ACCCBuzz Blog Posts

From Oncology Issues

  •  Engaging the Community to Improve Patient-Centered Care for Inflammatory Breast Cancer
    Gayathri R. Devi, PhD, et al.
    Through a community engagement session and focused interviews, researchers from Duke University School of Medicine, N.C., held a consortium to help stakeholders identify barriers to inflammatory breast cancer awareness, diagnosis, and appropriate treatment. Today the Duke Consortium for Inflammatory Breast Cancer is committed to translating research into action.
  •  The Inherited Cancer Registry (ICARE) Initiative
    Tuya Pal, MD, FACMG; Cristi Radford, MS, CGC; Anne Weidner, MPH; Ann Louise Tezak, MA, MPH; Deborah Cragun, PhD, MS, CGC; and Georgia Lowrey Wiesner, MD, MS
    The Inherited Cancer Registry (ICARE) is an academic-community partnership among healthcare providers, researchers, and individuals at an increased risk for inherited cancer. Learn about ICARE’s research registry for high-risk individuals and education efforts on inherited cancer for both patients and providers.
  •  Highlights from ASCO 2018
    By Cary A. Presant, MD, FACP, FASCO
    ASCO 2018 offered a wealth of new data that will continue to transform clinical practice and cancer program development. Most important, implementation of the scientifi c advances we learned at ASCO 2018 will improve the length and quality of life of our cancer patients.

In the News